ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 659948 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 659948; 2) Community: the network communities that were significantly associated with the response to NSC 659948; 3) Molecule: the relationships between components within communities and NSC 659948; 4) MDR: the compounds that were significantly associated with the NSC 659948.

NSC Compound Enrichment Correlation
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.0244632509325736 0.098098451
NSC 702348 Null 0.0244632509325736 0.038990987
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.0244632509325736 -0.084644857
NSC 763186 Null 0.0244632509325736 -0.08696057
NSC 94600 Camptothecin 0.0244632509325736 0.68132307
NSC 99733 Rheumygin 0.0244632509325736 0.28690507
NSC 185049 Hydrazinecarbothioamide, 2-[[5-(1-oxopropoxy)-2-pyridinyl]methylene]- 0.0244718705444135 0.39744973
NSC 320846 Batracylin, Daniquidone 0.0244718705444135 0.50121731
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0244718705444135 0.28949421
NSC 610456 Camptothecin Derivative 0.0244718705444135 0.72898302
Total:75  Current:40    [First] [Prev] [Next] [Last]